These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36140394)

  • 21. The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors.
    Hughes TD; Güner OF; Iradukunda EC; Phillips RS; Bowen JP
    Molecules; 2022 Jan; 27(1):. PubMed ID: 35011505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kynurenine Monooxygenase Expression and Activity in Human Astrocytomas.
    Vázquez Cervantes GI; Pineda B; Ramírez Ortega D; Salazar A; González Esquivel DF; Rembao D; Zavala Vega S; Gómez-Manzo S; Pérez de la Cruz G; Pérez de la Cruz V
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition.
    Phillips RS; Iradukunda EC; Hughes T; Bowen JP
    Front Mol Biosci; 2019; 6():3. PubMed ID: 30800661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.
    Schwarcz R; Guidetti P; Sathyasaikumar KV; Muchowski PJ
    Prog Neurobiol; 2010 Feb; 90(2):230-45. PubMed ID: 19394403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variants of the kynurenine-3-monooxygenase and postpartum depressive symptoms after cesarean section in Chinese women.
    Wang SY; Duan KM; Tan XF; Yin JY; Mao XY; Zheng W; Wang CY; Yang M; Peng C; Zhou HH; Liu ZQ
    J Affect Disord; 2017 Jun; 215():94-101. PubMed ID: 28319697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kynurenine monooxygenase regulates inflammation during critical illness and recovery in experimental acute pancreatitis.
    Hayes AJ; Zheng X; O'Kelly J; Neyton LPA; Bochkina NA; Uings I; Liddle J; Baillie JK; Just G; Binnie M; Homer NZM; Murray TBJ; Baily J; McGuire K; Skouras C; Garden OJ; Webster SP; Iredale JP; Howie SEM; Mole DJ
    Cell Rep; 2023 Aug; 42(8):112763. PubMed ID: 37478012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant Huntingtin Protein Interaction Map Implicates Dysregulation of Multiple Cellular Pathways in Neurodegeneration of Huntington's Disease.
    Podvin S; Rosenthal SB; Poon W; Wei E; Fisch KM; Hook V
    J Huntingtons Dis; 2022; 11(3):243-267. PubMed ID: 35871359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking.
    Orr AL; Li S; Wang CE; Li H; Wang J; Rong J; Xu X; Mastroberardino PG; Greenamyre JT; Li XJ
    J Neurosci; 2008 Mar; 28(11):2783-92. PubMed ID: 18337408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation.
    Wong YC; Holzbaur EL
    J Neurosci; 2014 Jan; 34(4):1293-305. PubMed ID: 24453320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial membranes modify mutant huntingtin aggregation.
    Adegbuyiro A; Sedighi F; Jain P; Pinti MV; Siriwardhana C; Hollander JM; Legleiter J
    Biochim Biophys Acta Biomembr; 2021 Oct; 1863(10):183663. PubMed ID: 34089719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease.
    Beaumont V; Mrzljak L; Dijkman U; Freije R; Heins M; Rassoulpour A; Tombaugh G; Gelman S; Bradaia A; Steidl E; Gleyzes M; Heikkinen T; Lehtimäki K; Puoliväli J; Kontkanen O; Javier RM; Neagoe I; Deisemann H; Winkler D; Ebneth A; Khetarpal V; Toledo-Sherman L; Dominguez C; Park LC; Munoz-Sanjuan I
    Exp Neurol; 2016 Aug; 282():99-118. PubMed ID: 27163548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kynurenine pathway and neurodegenerative disease.
    Maddison DC; Giorgini F
    Semin Cell Dev Biol; 2015 Apr; 40():134-41. PubMed ID: 25773161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion.
    Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S
    J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites.
    Zhang S; Sakuma M; Deora GS; Levy CW; Klausing A; Breda C; Read KD; Edlin CD; Ross BP; Wright Muelas M; Day PJ; O'Hagan S; Kell DB; Schwarcz R; Leys D; Heyes DJ; Giorgini F; Scrutton NS
    Commun Biol; 2019; 2():271. PubMed ID: 31372510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
    Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
    Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.
    van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ
    BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
    Lee WC; Yoshihara M; Littleton JT
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kynurenine 3-monooxygenase limits de novo NAD
    Zhai Y; Chavez JA; D'Aquino KE; Meng R; Nawrocki AR; Pocai A; Wang L; Ma LJ
    Am J Physiol Cell Physiol; 2024 May; 326(5):C1423-C1436. PubMed ID: 38497113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surface Expression of Kynurenine 3-Monooxygenase Promotes Proliferation and Metastasis in Triple-Negative Breast Cancers.
    Lai MH; Liao CH; Tsai NM; Chang KF; Liu CC; Chiu YH; Huang KC; Lin CS
    Cancer Control; 2021; 28():10732748211009245. PubMed ID: 33887987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.